Correction: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial

• Haitham G. Zakaraia,
• Heba F. Salem,
• Mostafa A. A. Mostafa,
• Ahmed M. Ali,
• Hoda M. Rabea

Affiliations

Haitham G. Zakaraia

Clinical Pharmacy Department, Faculty of Pharmacy, University of Sadat City

Heba F. Salem

Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Beni-Suef University

Mostafa A. A. Mostafa

Internal Medicine Department, Faculty of Medicine, October 6 University

Ahmed M. Ali

Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University

Hoda M. Rabea

Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University